Treatment of advanced Hodgkin's disease with vinblastine (NSC-49842) or procarbazine (NSC-77213).
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001565:Benzoates / Q000627:therapeutic use*; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001565:Benzoates; D014747:Vinblastine